In 283 adults with non-insulin-treated type 2 diabetes in US primary care, CGM lowered HbA1c more than routine care at 26 weeks (8.8% to 7.2% vs 8.7% to 8.0%; adjusted difference −0.9 points), with 21 points more time in range and no severe hypoglycaemia.
RCTn = 283
Oser et al. Continuous Glucose Monitoring in Non-Insulin-Treated Type 2 Diabetes